Search Results - peter+mullen

1 Results

Sort By:

2020-940 USE OF MTORC1 INHIBITORS TO TREAT COVID-19

UCLA researchers in the Department of Biological Chemistry have implicated a novel marker in SARS-CoV-2 infection, identifying a novel drug target for therapeutics treating COVID-19.BACKGROUNDSevere acute respiratory syndrome coronavirus-2, or SARS-CoV-2, is the virus responsible for the 2019 global pandemic (COVID-19): which caused hundreds of millions...

Published: 9/5/2023 | Inventor(s): Heather Christofk, Peter Mullen, Vaithilingaraja Arumugaswami

Keywords(s): Therapeutics & Vaccines

Category(s): Therapeutics